Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 12—December 2024
Research
Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh
Table 4
Discounted incremental outcomes |
Routine immunization birth cohorts |
Strategy 1, subnational campaign + subnational routine† |
Strategy 2, subnational campaign + national routine‡ |
Strategy 3, national routine§ |
|||||
Govt |
Soc |
Govt |
Soc |
Govt |
Soc |
||||
Discounted healthcare costs averted through vaccination |
10 | 5.3M | 55.8M | 8.5M | 90.1M | 5.7M | 60.1M | ||
20 |
7.1M |
75.1M |
12.7M |
134.8M |
9.9M |
104.8M |
|||
Deterministic ICER: cost per DALY averted |
10 | 892 | 23 | 955 | 60 | 1,066 | 126 | ||
20 |
981 |
94 |
1,053 |
143 |
1,149 |
208 |
|||
Deterministic ICER: cost per case averted |
10 | 9,046 | 230 | 9,710 | 609 | 10,888 | 1,283 | ||
20 |
9,964 |
958 |
10,720 |
1,458 |
11,733 |
2,128 |
|||
Deterministic ICER: cost per death averted |
10 | 45,230 | 1,148 | 48,549 | 3,045 | 54,441 | 6,413 | ||
20 |
49,819 |
4,790 |
53,601 |
7,290 |
58,667 |
10,640 |
|||
Probabilistic ICER: cost per DALY averted, mean (95% CI) |
10 | 991 (358–2,272) | 173 (–632 to 1,719) | 1,351 (453–3,469) | 196 (–501 to 2,614) | 1,374 (439–3,557) | 445 (–644 to 2,430) | ||
20 |
1,198 (444 to 2,807) |
307 (–538 to 1,971) |
1,249 (352 to 2,684) |
377 (–593 to 2,520) |
1,394 (559 to 2,834) |
560 (–475 to 2,879) |
|||
*Values are in US dollars. DALY, disability-adjusted life year; ICER, incremental cost-effectiveness ratio; govt, governmental costs; soc, societal costs. †Subnational 1-time immunization campaign for children <15 years of age and subnational routine immunization for 9-month-old children. The subnational approach focuses on 3 divisions with a high number of JE cases: Rangpur, Rajshahi, and Chattogram. ‡Subnational 1-time immunization campaign and national routine immunization. §National routine immunization only. |
1These first authors contributed equally to this article.
Page created: August 29, 2024
Page updated: November 20, 2024
Page reviewed: November 20, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.